Professor Elizabeth A Magnuson
Saint Luke's Hospital, Kansas City (United States of America)
Hospitalization-related costs among patients with atrial fibrillation treated with the factor Xa inhibitor edoxaban vs warfarin: results from the ENGAGE AF-TIMI 48 trial
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Antithrombotic therapy in atrial fibrillation 2
ESC 365 is supported by
